1. Home
  2. MRAM vs TTRX Comparison

MRAM vs TTRX Comparison

Compare MRAM & TTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Everspin Technologies Inc.

MRAM

Everspin Technologies Inc.

HOLD

Current Price

$16.37

Market Cap

353.8M

Sector

Technology

ML Signal

HOLD

Logo Turn Therapeutics Inc.

TTRX

Turn Therapeutics Inc.

N/A

Current Price

$9.80

Market Cap

298.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MRAM
TTRX
Founded
2008
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
353.8M
298.8M
IPO Year
2016
2025

Fundamental Metrics

Financial Performance
Metric
MRAM
TTRX
Price
$16.37
$9.80
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$18.50
$8.00
AVG Volume (30 Days)
1.1M
48.7K
Earning Date
04-29-2026
05-31-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$49,417,000.00
N/A
Revenue This Year
$10.22
N/A
Revenue Next Year
$7.38
N/A
P/E Ratio
N/A
N/A
Revenue Growth
37.51
N/A
52 Week Low
$6.81
$2.57
52 Week High
$51.50
$11.69

Technical Indicators

Market Signals
Indicator
MRAM
TTRX
Relative Strength Index (RSI) 44.42 58.87
Support Level $15.90 $9.04
Resistance Level $16.74 $10.72
Average True Range (ATR) 1.18 0.69
MACD -0.12 -0.04
Stochastic Oscillator 13.19 85.05

Price Performance

Historical Comparison
MRAM
TTRX

About MRAM Everspin Technologies Inc.

Everspin Technologies Inc is a manufacturer of Magnetoresistive Random Access Memory (MRAM) technology. The company manufactures MRAM products using both captive and third-party manufacturing capabilities. It purchases industry-standard complementary metal-oxide semiconductor (CMOS) wafers from semiconductor foundries and perform back end of line (BEOL) processing that includes magnetic-bit technology at leased 200mm fabrication facility in Chandler, Arizona. It also manufactures full-flow 300mm CMOS wafers with STT-MRAM magnetic-bit technology integrated in BEOL. The company's customers are in key markets, such as industrial, medical, automotive/transportation, aerospace, and data center.

About TTRX Turn Therapeutics Inc.

Turn Therapeutics Inc is a clinical-stage biotechnology and medical device development company built around its proprietary platform technology called PermaFusion designed to enhance drug performance. The company is developing non-systemic, non-biologic topical immunomodulators for inflammatory skin disease. Its program, GX-03, is being studied for moderate-to-severe eczema based on preclinical evidence of cytokine inhibition and reduced eczema severity, as well as a favorable real-world tolerability record from prior cleared medical device indications for the same formula. GX-03 is currently being evaluated in an ongoing, randomized, double-blind, vehicle-controlled clinical study designed to assess its potential as a topical treatment for moderate-to-severe eczema.

Share on Social Networks: